- Book
- June 2022
- 560 Pages
- Book
- June 2022
- 496 Pages
- Book
- April 2020
- 320 Pages
- Book
- February 2020
- 202 Pages
- Book
- September 2019
- 688 Pages
- Book
- December 2018
- 784 Pages
- Book
- July 2018
- 360 Pages
- Book
- April 2018
- 312 Pages
- Book
- February 2018
- 784 Pages
- Book
- February 2018
- 448 Pages
- Book
- March 2017
- 2008 Pages
- Book
- December 2011
- 200 Pages
- Book
- September 2010
- 544 Pages
- Book
- April 2010
- 351 Pages
- Book
- December 2023
- 864 Pages
- Book
- July 2023
- 320 Pages
- Book
- January 2023
- 304 Pages
- Book
- April 2022
- 656 Pages
Global
- Book
- November 2021
- 512 Pages
- Book
- January 2017
- 504 Pages
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more